Pharmaceutical Chemicals: United States
This report forecasts US pharmaceutical chemical demand in US dollars at the manufacturers' level to 2019. Total demand is segmented by therapeutic group in terms of central nervous system, hormones and related, cardiovascular, anti-infective, nutritional, biological, respiratory, and other therapeutic groups. Total demand is also segmented by source of supply as follows: captive/contract production and merchant market.
To illustrate historical trends, total demand is provided in an annual series from 2004 to 2014; the various segments are reported at five-year intervals for 2009 and 2014. A Market Environment section provides pertinent background on historical market size and trends, key economic indicators, merchant market trade, global merchant market demand, and regulatory environment. A Segmentation and Forecasts section defines therapeutic groups and sources of supply, discusses market drivers and constraints, identifies substitute products when applicable, and assesses the impact of key drivers and constraints on each therapeutic group and supply source segment over the forecast period.
Further analysis includes an Industry Structure section, which surveys the supply base and profiles the leading firms competing to serve US demand. A one-page, introductory Highlights section summarizes key findings from this 26-page report, and a Resources section lists contributing sources as well as resources available for further research.
Back to Top